215 related articles for article (PubMed ID: 30680929)
1. Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.
Hu S; Cheng M; Guo X; Wang S; Liu B; Jiang H; Huang C; Wu G
J Cell Mol Med; 2019 Apr; 23(4):2505-2516. PubMed ID: 30680929
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy.
Wang S; Cheng M; Hu Z; Hu S; Zou Q; Lai X; Liu B; Jiang H; Huang C; Wu G
Cell Physiol Biochem; 2017; 44(6):2281-2295. PubMed ID: 29262413
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
4. Role of microRNA-124 in cardiomyocyte hypertrophy inducedby angiotensin II.
Bao Q; Chen L; Li J; Zhao M; Wu S; Wu W; Liu X
Cell Mol Biol (Noisy-le-grand); 2017 Apr; 63(4):23-27. PubMed ID: 28478799
[TBL] [Abstract][Full Text] [Related]
5. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
6. β-adrenergic activation may promote myosin light chain kinase degradation through calpain in pressure overload-induced cardiac hypertrophy: β-adrenergic activation results in MLCK degradation.
Wang S; Wang H; Su X; Liu B; Wang L; Yan H; Mao S; Huang H; Huang C; Cheng M; Wu G
Biomed Pharmacother; 2020 Sep; 129():110438. PubMed ID: 32768940
[TBL] [Abstract][Full Text] [Related]
7. miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.
Guan X; Wang L; Liu Z; Guo X; Jiang Y; Lu Y; Peng Y; Liu T; Yang B; Shan H; Zhang Y; Xu C
J Mol Cell Cardiol; 2016 Oct; 99():207-217. PubMed ID: 27565029
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W
J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-297 promotes cardiomyocyte hypertrophy via targeting sigma-1 receptor.
Bao Q; Zhao M; Chen L; Wang Y; Wu S; Wu W; Liu X
Life Sci; 2017 Apr; 175():1-10. PubMed ID: 28286226
[TBL] [Abstract][Full Text] [Related]
10. Let-7a Is an Antihypertrophic Regulator in the Heart via Targeting Calmodulin.
Zhou X; Sun F; Luo S; Zhao W; Yang T; Zhang G; Gao M; Lu R; Shu Y; Mu W; Zhuang Y; Ding F; Xu C; Lu Y
Int J Biol Sci; 2017; 13(1):22-31. PubMed ID: 28123343
[No Abstract] [Full Text] [Related]
11. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.
Wang YS; Zhou J; Hong K; Cheng XS; Li YG
Cell Physiol Biochem; 2015; 35(4):1546-56. PubMed ID: 25792377
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
Xu X; Su YL; Shi JY; Lu Q; Chen C
Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p.
Ji H; Qu J; Peng W; Yang L
Int Heart J; 2022; 63(3):602-611. PubMed ID: 35650160
[TBL] [Abstract][Full Text] [Related]
15. MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy.
Li AL; Lv JB; Gao L
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5462-5470. PubMed ID: 29243791
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes.
Song XW; Li Q; Lin L; Wang XC; Li DF; Wang GK; Ren AJ; Wang YR; Qin YW; Yuan WJ; Jing Q
J Cell Physiol; 2010 Nov; 225(2):437-43. PubMed ID: 20458739
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathway.
Li L; Zhang ZG; Lei H; Wang C; Wu LP; Wang JY; Fu FY; Zhu WG; Wu LL
PLoS One; 2013; 8(1):e49915. PubMed ID: 23349663
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E1 attenuates AngII-induced cardiac hypertrophy via EP3 receptor activation and Netrin-1upregulation.
Shen Y; Wang X; Yuan R; Pan X; Yang X; Cai J; Li Y; Yin A; Xiao Q; Ji Q; Li Y; He B; Shen L
J Mol Cell Cardiol; 2021 Oct; 159():91-104. PubMed ID: 34147480
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin Attenuates Myocardial Hypertrophy Induced by Chronic Intermittent Hypoxia In Vitro Partly through miR-31/PKCε Pathway.
Ren J; Liu W; Li GC; Jin M; You ZX; Liu HG; Hu Y
Curr Med Sci; 2018 Jun; 38(3):405-412. PubMed ID: 30074205
[TBL] [Abstract][Full Text] [Related]
20. MiR-410-3p facilitates Angiotensin II-induced cardiac hypertrophy by targeting Smad7.
Jia G; Liang C; Li W; Dai H
Bioengineered; 2022 Jan; 13(1):119-127. PubMed ID: 34951337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
